To examine possible cooperation between FGFR2 variants and other genes, we analysed driver gene alterations diagnosed by FMI oncogenomic profiling and their incidence in FGFR2-altered cancers (Extended Data Fig. 10a and Supplementary Table 2). The gene discussed is FGFR2; the disease is cancer.